A Study Assessing the Safety and Utility of PINPOINT® Near Infrared Fluorescence Imaging in the Identification of Lymph Nodes in Patients With Uterine and Cervical Malignancies Who Are Undergoing Lymph Node Mapping

NCT02209532 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Endometrial Cancer
Uterine Cancer
Cervical Cancer

Interventions

DEVICE: PINPOINT

Sponsor

Novadaq Technologies ULC, now a part of Stryker